Trial completion date • Trial primary completion date
|
ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS) • NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1) • NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3) • NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2)
|
ALK rearrangement • ROS1 rearrangement
|
Xalkori (crizotinib) • Rozlytrek (entrectinib)